MercyIowaCityClinics.org is an independent editorial publication and is not affiliated with any hospital, clinic, or medical provider. This article may contain affiliate links. FTC disclosure required by 16 C.F.R. Part 255.
The Hard Truth: Keeps Isn't Reinventing Hair Loss Treatment—It's Repackaging It
Let's start here: Keeps is not selling you a miracle cure, a proprietary formula, or a secret compound developed in a lab in Switzerland. Keeps is a telemedicine platform that connects you to licensed healthcare providers who prescribe and ship FDA-approved hair loss medications—primarily finasteride (Propecia/generic) and minoxidil (Rogaine/generic). The MICC Review Team wants to be clear on this distinction because the company's marketing often obscures it beneath lifestyle photography, success testimonials, and language that suggests innovation where there is administrative convenience.
That said, there is legitimate value in what Keeps does—just not the value the homepage marketing implies. The real question isn't whether the medications work. They do. The question is whether paying Keeps' subscription fees and convenience markup is the right financial and medical decision for you.
What Keeps Actually Delivers: Service Model vs. Medication
Keeps operates on a straightforward three-step model: (1) you complete an online health questionnaire, (2) a licensed dermatologist or physician reviews your case and determines eligibility, (3) medications are shipped to your door monthly. The company does NOT manufacture any drugs. It sources FDA-approved generic or brand-name medications and delivers them under a subscription model with pricing that typically ranges from $40–$75 per month depending on your prescribed regimen.
This is important because marketing materials often present the service with language that implies Keeps has created something novel. The homepage states customers should “answer a few questions and our Care Team will help you find the best hair treatment plan”—language that suggests personalized pharmaceutical design. In reality, your “treatment plan” is selecting from a menu of two medications that have been the standard for male pattern baldness treatment for 25+ years.
The genuine operational advantages: (1) You avoid scheduling a dermatology appointment (which can take weeks), (2) you skip the pharmacy copay conversation with insurance, (3) medications arrive at your door discreetly, and (4) the platform theoretically removes barriers to consistent adherence. Whether these conveniences justify the cost markup over generic pharmacy pricing requires honest comparison shopping—which Keeps marketing does not encourage.
Ingredient Analysis: The Active Compounds Behind the Service
Keeps primarily dispenses two FDA-approved medications for androgenetic alopecia (male pattern baldness):
Finasteride (5-alpha reductase inhibitor): Typical dose 1 mg daily. Finasteride blocks the conversion of testosterone to DHT (dihydrotestosterone), the hormone responsible for pattern baldness in genetically susceptible men. Clinical evidence is robust: a 1998 meta-analysis in the *Journal of the American Academy of Dermatology* showed 83% of men using finasteride experienced hair loss stabilization, with 48% showing visible regrowth over 2 years. Importantly, efficacy plateaus around 18–24 months; finasteride halts progression but rarely triggers dramatic density recovery.
Minoxidil (topical vasodilator): Typically 5% topical solution, applied twice daily. Minoxidil works through a different mechanism—it extends the anagen (growth) phase and increases blood flow to hair follicles. The FDA approved minoxidil for topical use in 1988. Response rates are similar to finasteride (~40% visible regrowth, ~40% stabilization, ~20% no response). Clinical advantage: minoxidil can be combined with finasteride for additive effect.
Evidence Grade: Both medications have Level 1 evidence support in dermatology literature. Neither is experimental. The clinical bar Keeps clears is low because the bar itself was set 25+ years ago.
Common Side Effects (Not Discussed in Keeps Marketing): Finasteride carries a 2–3% incidence of sexual side effects in clinical trials (erectile dysfunction, decreased libido). Minoxidil can cause scalp irritation and, if swallowed, systemic absorption effects. Some users report dizziness or palpitations with topical minoxidil. Keeps' online questionnaire does collect this information, but the homepage marketing never mentions these risks—a predictable omission for a revenue-dependent company.
Pricing and Financial Reality Check
Keeps' advertised pricing:
- Finasteride monotherapy: ~$40–$60/month (billed as “$75 regular price—on sale now”)
- Minoxidil: ~$40–$60/month
- Combination therapy: ~$70–$120/month
The “regular price” claim is a classic direct-to-consumer marketing tactic. Keeps does not actually charge the “regular” higher price to anyone; it is a psychological anchor designed to inflate perceived value.
Comparative cost analysis: A 30-day generic finasteride prescription (90 tablets of 1mg) costs $15–$40 at Walmart, CVS, or GoodRx depending on insurance. Minoxidil (5% solution, 2–3 month supply) ranges $20–$50. Total out-of-pocket for both medications combined: approximately $35–$90 per month using retail pharmacy chains—comparable to or cheaper than Keeps, depending on your insurance coverage. If you have insurance with a dermatology copay ($20–$50 per visit, potentially once or twice per year), traditional dermatology visits are financially competitive with the telemedicine subscription model.
Where Keeps has genuine cost advantage: for uninsured men without access to dermatologists, or for men in geographic regions where dermatology wait times exceed 6 months. For everyone else, the financial math favors traditional pharmacy + occasional in-person dermatology consultation.
Real User Feedback: Separating Testimonial Theater from Actual Experience
Keeps' homepage features success stories with photographic before/afters. These are not scientifically uncontrolled—they are selected testimonials from a self-selected population of satisfied customers. This is not fraud, but it is marketing selection bias. Men who saw no improvement do not submit photos.
What independent user forums report: Reddit threads, TrustPilot reviews, and hair loss community forums reveal a more granular picture:
- Positive reports (40–50% of reviews): “The convenience is real—I don't have to schedule a dermatology appointment.” “Customer service was responsive when I had questions.” “The medications arrived on schedule.”
- Qualified positive (20–30%): “The service is good, but the medications are the same as generic pharmacy—you're paying for convenience, not efficacy.”
- Negative (15–25%): “The monthly subscription feels extractive.” “Side effects were not discussed adequately during the initial consultation.” “Customer service became unresponsive after I started having questions about adverse effects.” “Cancellation process is intentionally difficult.”
A recurring complaint: the initial physician consultation is cursory (typically 10–15 minutes of asynchronous review), and ongoing medication adjustments require paying for “follow-up” consultations even though the medications and dosages remain unchanged month-to-month.
Marketing Red Flags the MICC Team Identified
1. Fake Urgency (“Limited Time Offer”): Keeps perpetually advertises “special introductory pricing” and “limited-time discounts.” These are permanent. No one ever pays the “regular price.”
2. Vague Authority Appeals: The site refers to “FDA-approved medications” without clarifying that the FDA approved the *medications* 25 years ago, not Keeps' specific formulations or service model.
3. Testimonial Absence of Diversity: Success photos are heavily weighted toward young men (20s–40s) with early-stage hair loss. Men with advanced baldness or poor medication response are absent—not because they don't use Keeps, but because Keeps doesn't feature them.
4. Privacy Language as Marketing: Keeps emphasizes “discreet delivery” and “private consultations.” While legitimate privacy protections exist, the marketing exploits potential shame around hair loss to drive urgency and bypass comparison shopping.
MICC Team Verdict: Who Should Consider Keeps, Who Should Skip It
Consider Keeps if:
- You live in a region with severe dermatology access gaps (rural areas, long wait times).
- You are uninsured and cannot negotiate pharmacy pricing.
- You have a documented need for consistent medication adherence reminders and monthly follow-ups.
- You strongly prefer avoiding in-person consultations and have no comorbidities complicating the decision.
Skip Keeps if:
- You have insurance with dermatology coverage. A single dermatology visit followed by generic pharmacy refills is cheaper and medically superior.
- You have existing cardiovascular conditions, sexual dysfunction history, or take medications with potential interactions. You need an in-person evaluation, not an online questionnaire.
- You are price-sensitive. Generic finasteride + minoxidil at a chain pharmacy will cost you 20–40% less.
- You expect the service to solve advanced or treatment-resistant baldness. These medications work for early-to-moderate hair loss; severe baldness requires hair transplantation, which Keeps does not address.
Frequently Asked Questions
Does Keeps actually work better than buying medications from a traditional pharmacy?
No. Keeps dispenses the same FDA-approved medications sold at any pharmacy. The active ingredients are chemically identical. The difference is administrative access and pricing structure. Some users report better adherence because the subscription model creates a reminder system, but that is behavioral, not pharmaceutical.
What happens if you experience side effects while using Keeps?
You message your Keeps provider through the app. Response times are typically 24–48 hours. However, if you experience acute symptoms (chest pain, severe headache, severe sexual dysfunction), you should contact an emergency department or your primary care doctor, not Keeps. The platform is not equipped for acute care escalation.
Can you use Keeps if you're already on other medications?
Keeps' questionnaire collects medication history. However, the online physician's review is abbreviated. If you take medications affecting cardiac function, blood pressure, or sexual function, an in-person dermatology consultation is medically prudent. Finasteride and minoxidil both affect systemic physiology, and interaction risks require deeper evaluation than a form review permits.
Is hair regrowth guaranteed with Keeps?
No. Approximately 40% of users experience visible regrowth, 40% experience stabilization (no further loss), and 20% see no response. Individual response is determined by genetics, not by which service you use. Keeps cannot change your baseline hair genetics.
Final Word: Legitimate Service, Inflated Marketing
Keeps solves a real access problem—dermatology appointments are hard to get, and telemedicine removes friction. But the company exploits that convenience by wrapping commodity medications in lifestyle branding and manufactured urgency. For men with straightforward early-stage hair loss and access barriers to traditional dermatology, Keeps is a reasonable option. For everyone else, it is an expensive convenience tax on medications you could obtain cheaper elsewhere.
The medications Keeps prescribes work. The service model is competent. The marketing is deliberately designed to obscure that you are not paying a premium for better drugs—you are paying a premium for convenience and the psychological comfort of mediated shame avoidance. That's a legitimate choice. Just be honest about what you're buying.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement or medication, especially if you have pre-existing cardiovascular conditions, take blood pressure medications, or have a history of sexual dysfunction.